CRCL Clears $130 as Circle Pulls $222M for Arc From BlackRock and a16z

The Presale, Not the Print

CRCL prints $133.90 on the Hyperliquid perp after a five-hour, 18.84% advance that maps to Circle's Q1 2026 webcast — but the print itself isn't the driver. EPS of $0.21 beat the $0.17 consensus, revenue of $694M missed the $715M estimate by roughly 3%, and net income from continuing operations fell 15% YoY to $55M. A clean EPS beat against a soft revenue line shouldn't print a 19-handle move on its own. What did: Circle disclosed alongside earnings that it raised $222M in a presale of the Arc token at a $3B fully diluted valuation, with a16z crypto leading at $75M and BlackRock, Apollo Funds, ARK Invest, Bullish, General Catalyst, Haun Ventures, Intercontinental Exchange, IDG Capital, Janus Henderson, Marshall Wace, SBI Group, and Standard Chartered Ventures joining. Circle is the first publicly listed company to run a token presale, and the names on the cap table are precisely the ones the bear thesis assumed would never sign.

Why $3B FDV Is The Number

Arc is a USDC-native L1 with EVM compatibility, sub-second finality, and opt-in privacy. The public testnet launched in October 2025 with more than 100 institutional participants including BlackRock, Visa, Goldman Sachs, Anthropic, and AWS — so the $3B valuation is being paid against an institutional userbase that already exists, not a whitepaper. Circle holds 25% of the initial 10B-token supply, 60% routes to builders and users, and 15% sits in a long-term reserve. The structural read: Circle now has a second equity claim on USDC-as-gas, layered on top of the reserve-income line that drove the Q1 revenue miss in the first place. The Q1 guidance explicitly excludes Arc revenue and incentive programs, which means the model the sell-side was running into today's print no longer covers the asset that's now repricing it.

What Just Got Invalidated

The bear setup going into earnings was clean. CRCL had faded from $122 to $113.20 by May 8 on a 17-hour distribution day, insiders distributed at the high under pre-arranged 10b5-1 plans — director Burns offloaded 11,666 shares at a weighted $120.15 and director Neville sold 30,000 shares the same week — and Compass Point's standing $77 Sell target framed the print as a multiple-compression risk. CRCL just cleared all of that on a single five-hour bar. The operating story carries the floor: Adjusted EBITDA of $151M grew 24% YoY, USDC in circulation hit $77B (+28% YoY), and onchain transaction volume reached $21.5 trillion, up 263% YoY. The Arc presale carries the multiple. The asset that was supposed to test $77 is now trading 74% above it on a confirmed institutional cap table.

What To Watch

Arc mainnet timing and the unlock schedule for the token allocation aren't in the earnings release — that's the next discrete catalyst, and any disclosure gets repriced directly because guidance explicitly excludes it. On the downside, the underlying NYSE tape was reportedly violent — intraday spot swung from +8% to -6% before stabilizing — so the Hyperliquid perp is sitting above a thin and contested order book. The revenue miss isn't dead either: if Arc revenue takes more than a few quarters to land, the $694M reserve-income line is the number the next bear thesis will defend, and the 15% YoY profit decline is the soft spot that still scales with rate cuts.